What does share repurchase authorization limit mean?

This represents the total dollar value or share count that the board of directors has authorized the company to spend on repurchasing its own common stock from the open market. It serves as a signal of management's confidence in the company's valuation and its commitment to returning capital to shareholders. This limit is an authorization, not an obligation to spend.

ADMA Biologics ADMA Share Repurchase Authorization Limit

Share Repurchase Authorization Limit at other companies

AmgenAMGN

——

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept srt:StockRepurchaseProgramAuthorizedAmount1.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's share repurchase authorization limit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's share repurchase authorization limit?: ADMA Biologics (ADMA) reported share repurchase authorization limit of $500M in Q2 2025.
What does share repurchase authorization limit mean?: This represents the total dollar value or share count that the board of directors has authorized the company to spend on repurchasing its own common stock from the open market. It serves as a signal of management's confidence in the company's valuation and its commitment to returning capital to shareholders. This limit is an authorization, not an obligation to spend.